Options for Inspections
Order PT/EQA for 2022 Today
The CAP partners with laboratories in the continuous pursuit of operational excellence and diagnostic confidence to improve patient outcomes. Our proficiency testing and external quality assessment (PT/EQA) programs help you deliver performance you can measure, accuracy you can trust.
Multidisciplinary Breast Pathology
Switch to Direct Transmission Today
SARS-CoV-2 Assays
Live Inspector Training
Join us for this complimentary inspector training program specifically designed for the unique needs of molecular pathology inspectors. CME/CE is available.
Next-Generation Sequencing
Precision Medicine Resource Center
Peripheral Blood Smears
Pathology in the Park 2022
CAP Today
Archives of Pathology & Laboratory Medicine
Catalog and Shipping Information
Publications Catalog
Upcoming Events
View All Events-
CAP House of Delegates
Sep 25, 2021Hyatt Regency Chicago, Chicago, IL
-
American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo
Sep 26, 2021 - Sep 30, 2021Atlanta, GA
COVID-19 Information
The CAP accreditation program adds virtual inspections during pandemic
Latest News from the CAP
-
FDA Welcomes the CAP to its Network of Experts
Read More -
CAP Statement Against Misleading COVID-19 Information
Read More -
CAP Supports Vaccine Requirements for Physicians and Other Health Care Professionals Caring for Patients
Read More -
New CAP Guideline Improves Diagnoses of Patients with Monoclonal Gammopathies
Read More
Life for Laboratories after COVID-19 Media Briefing
The College of American Pathologists (CAP) recently hosted its second virtual media forum of 2021, Life for Laboratories after COVID-19, in its ongoing commitment to educating media and the public on COVID-19 testing and the pandemic.
During the session, which was moderated by Speaker of the CAP House of Delegates Kathryn Knight, MD, FCAP, CAP President Patrick Godbey, MD, FCAP and Chair of the Council on Government and Professional Affairs Jonathan Myles, MD, FCAP discussed the challenges of managing the impact of COVID-19 on laboratories and patient access. The group also discussed the impact of the latest COVID-19 federal testing programs during the first 100 days of the Biden administration. Additionally, the group discussed the implications for patients who postponed their care because of the pandemic and the issues laboratories face when patients come back for care.